In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA‑4, in B‑cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

In vitro and in vivo effects of AVA4746, a novel competitive antagonist of the ligand binding of VLA‑4, in B‑cell acute lymphoblastic leukemia

Published:2021-11-15 Issue:1 Volume:23 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Ruan Yongsheng¹,Kim Hye¹,Ogana Heather¹,Gang Eun¹,Li Shuangyue¹,Liu Hsiao-Chuan²,Bhojwani Deepa¹,Wayne Alan ¹,Yang Mo³,Kim Yong-Mi¹

Affiliation:

1. Department of Pediatrics, Division of Hematology‑Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA

2. Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA

3. Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrin-deficient T cell leukemia accumulates in the central nervous system;2024-07-02

2. Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific ⁸⁹Zr-Labeled Natalizumab Immuno-Positron Emission Tomography;Molecular Pharmaceutics;2024-01-29

3. Contribution of the TIME in BCP-ALL: the basis for novel approaches therapeutics;Frontiers in Immunology;2024-01-17

4. Applying Rituximab During the Conditioning Regimen Prevents Epstein–Barr Virus Infection Following Allogeneic Hematopoietic Stem Cell Transplant in a Children’s Cohort: A Retrospective Case–Control Study;Infectious Diseases and Therapy;2023-07-20

5. Targeting integrins in drug‐resistant acute myeloid leukaemia;British Journal of Pharmacology;2023-06-19